David Schumann examines some specs from the past that failed to pan out, asking why they failed and what to avoid in the future.

Jason Alt looks at the out-of-control hype that followed close on the heals of the PT, the Pro Tour itself, and results from SCG St. Louis.

Matthew Lewis looks at aggregate set prices for Innistrad block, which have been on the move, and their current relation to redemption.

Jason Alt discusses the unexpected in buylist prices, Legacy pet-deck results, and the Finance Subreddit’s reaction to calls.

Matthew Lewis looks at the state of his MTGO portfolio and the cards he’s moving on right now.

With the Modern Pro Tour right around the corner, Corbin looks at relevant spec targets, some sure-fire and some more speculative.

Ryan ruminates on the direction Modern might head in the coming months.

There’s no debate that price gainers lead to profitable opportunities. But each week mtgstocks.com reports top losers as well. These data can provide us with important insights.

This week Jason Alt looks at TCG buyouts, the defection of entire pro teams, and the (lackluster) mythics spoiled from Born of the Gods.

Danny questions what the next set might bring to Standard, and what to do about Modern with the PTQ season still so far away.

This week Jason Alt explains the difference between sheep and speculators in his usual mix of insight and snark.

Last year Scars block missed out on the Modern spike, but it appears the block is finally old enough for gains. Today Sigmund explores this trend.

Matthew Lewis returns to the digital-to-paper ratio, focusing on Innistrad block, which has deviated slightly from the typical pattern.